Skip to main content

Pioglitazone (International)

In the US, Pioglitazone (pioglitazone systemic) is a member of the drug class thiazolidinediones and is used to treat Nonalcoholic Steatohepatitis and Type 2 Diabetes.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BG03

CAS registry number (Chemical Abstracts Service)

0111025-46-8

Chemical Formula

C19-H20-N2-O3-S

Molecular Weight

356

Therapeutic Category

Oral antidiabetic agent: Insulin sensitizer, thiazolidinedione (glitazone)

Chemical Names

(+/-)-5-[p-[2-(5-Etyl-2-pyridyl)etoxy]benzyl]-2,4-tiazolidinedione (WHO)

2,4-tiazolidinedione, 5-((4-(2-(5-etyl-2-pyridinyl)etoxy)phenyl)metyl)-, (+-)-

2,4-tiazolidinedione, 5-((4-(2-(5-etyl-2-pyridinyl)etoxy)phenyl)metyl)-, monohydrochloride, (+-)- (USAN)

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs